drugset / Trial / NCT03053219
Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate safety and efficacy of male Patients With Advanced NSCLC who participant in \[14C\] AC0010 ADME.
Timeline
- Start
- 2016-11
- Primary completion
- 2018-07
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abivertinib | Small molecule | 300 mg | Oral |